Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 535.26 Billion | USD 984.05 Billion | 7% | 2023 |
According to Zion Market Research, the global Elective Healthcare Services Market was worth USD 535.26 Billion in 2023. The market is forecast to reach USD 984.05 Billion by 2032, growing at a compound annual growth rate (CAGR) of 7% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Elective Healthcare Services Market industry over the next decade.Request Free Sample
The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on value (USD Billion).
Elective healthcare services are those services that are selected by the patient or a doctor that can benefit the patient but are not urgently required. It includes aesthetic services like Injectables, hair & tattoo removal, and cosmeceuticals. Apart from this, elective healthcare services also comprise medically benefitting but not immediately requiring medical services like apnea, gastrointestinal disorder, allergies, pain management, and weight loss.
Furthermore, the emerging tide of consumerism witnessed across the healthcare sector has not only empowered the patient but has provided the healthcare service provider with an opportunity to engage with the patient. Moreover, creating value for the patients is the major aim of healthcare service providers.
In the patient-centric elective healthcare services industry, healthcare service providers have to consistently change their business models for providing cost-effective elective healthcare solutions to patients along with delivering sustainable business growth for their firms. Apparently, the elective healthcare services industry is strongly influenced by the best benchmarking business practices adopted by the players to acquire the best outcomes.
Growing demand for rescheduling of elective healthcare services after the re-opening of hospitals in the countries like the U.S. in the midst of COVID – 19 pandemic will prompt market growth over the estimated timespan. Moreover, the preference of patients to get admitted to ambulatory centers for in-patient treatments will create lucrative growth avenues for the elective healthcare services market in the years ahead. The growing trend among healthcare service providers to shift outpatients from hospitals to ambulatory surgical clinics after surgery is likely will promote business growth in the foreseeable future.
Furthermore, the utilization of new elective healthcare service models for enhancing the accessibility as well as affordability of these services for patients will spearhead the growth of the industry over the coming decade. Governments across the globe are making every effort for these elective healthcare services to reach the people residing in distant places as well as make them easily available for the patients who are classified at the bottom of the pyramid group. All these aforementioned factors will augment the market growth over the years ahead.
Moreover, individuals are adopting virtual care alternatives like telehealth due to the COVID-19 crisis and this will further boost the market trends. Apparently, a prominent surge in a video consultation with doctors, telephonic consultation, self-health monitoring, remote monitoring, digital therapeutics, mail-order pharmacy, and online communication will prop up the expansion of the elective healthcare services industry over the forecasting timeline.
Healthcare service providers are opting for virtual care services that include providing of healthcare solutions through virtual, remote, and digital channels. This will increase the global reach of elective healthcare services. Apart from this, the move will assist the healthcare service providers in improving their engagement with the patients along with fulfilling the medical requirements of the people through the digital medium. All these aspects will raise the profitability of the elective healthcare services industry over the forecasting timeline.
North America is likely to capture a huge chunk of the global market share over the forecast timespan. The regional market growth is credited to large-scale unmet medical needs of the patients in the countries of North America due to spur in the COVID pandemic witnessed across the countries like the U.S. Apart from this, a large number of patients in the U.S. are eager for rescheduling their postponed elective healthcare treatment within six months.
This will embellish the market earnings in the region over years ahead. For the record, among the patients surveyed for rescheduling of electric healthcare treatment within 6 months in the U.S. during May 2020, it was found that nearly 83% opted for office visits, 80% selected diagnostic testing at labs, 70% opted for outpatient service settings, and 59% wanted inpatient service settings.
Report Attributes | Report Details |
---|---|
Report Name | Elective Healthcare Services Market |
Market Size in 2023 | USD 535.26 Billion |
Market Forecast in 2032 | USD 984.05 Billion |
Growth Rate | CAGR of 7% |
Number of Pages | 110 |
Key Companies Covered | Fortis Healthcare, Tata Memorial Hospital, Apollo Hospital, Shanghai Redleaf International Women’s & Children’s Hospital, IHH Healthcare Berhad, Luye Medical Group, Capio AB, Moorfields Eye Hospital, Ramsay Générale de Santé, PillPack, Guizhou Ensure Chain Pharmacy Company Limited, and Fresenius Medical Care. |
Segments Covered | By Product Type, By Application, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The participants are focusing on providing high-quality healthcare facilities at affordable costs to the patients by adopting proficient elective healthcare service delivery models. These players are investing heavily in digital innovation for boosting their healthcare infrastructure facility and are fulfilling the changing end-user requirements along with strictly adhering to regulatory compliance, thereby contributing sizably towards the overall market size.
Key players influencing the market growth are
By Application:
By Region
FrequentlyAsked Questions
Humungous necessity of rescheduling of elective healthcare activities after re-opening of clinics in the countries such as the U.S. in the midst of COVID – 19 outbreak will promote the business growth over the estimated timespan. Moreover, the growing patient trend to get admitted to ambulatory centers for in-patient treatments will produce lucrative growth avenues for the elective healthcare services industry in the foreseeable future.
According to Zion Market Research, the global Elective Healthcare Services Market was worth USD 535.26 Billion in 2023. The market is forecast to reach USD 984.05 Billion by 2032, growing at a compound annual growth rate (CAGR) of 7% during the forecast period 2024-2032.
North America is projected to make notable contributions towards overall market earnings during the forecast timeline. The regional industry surge is credited to large-scale unmet medical needs of the patients in the countries of North America due to surge in the COVID pandemic witnessed across the countries such as the U.S. In addition to this, large-number of patients in the U.S. are eager for rearranging their postponed elective healthcare treatment within next six months.
The key players profiled in the report are Fortis Healthcare, Tata Memorial Hospital, Apollo Hospital, Shanghai Redleaf International Women’s & Children’s Hospital, IHH Healthcare Berhad, Luye Medical Group, Capio AB, Moorfields Eye Hospital, Ramsay Générale de Santé, PillPack, Guizhou Ensure Chain Pharmacy Company Limited, and Fresenius Medical Care.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed